Eric A. Kitas
32Patents
6h-index
67Co-inventors
68Inventor score
Filing activity: Jul 6, 2001 → Sep 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8501930B2 | Peptide-based in vivo siRNA delivery system | Chemistry; Metallurgy | 88 | Active |
| US7160875B2 | Malonamide derivatives | Chemistry; Metallurgy | 19 | Expired |
| US9796756B2 | Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA | Chemistry; Metallurgy | 15 | Active |
| US8426554B2 | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages | Chemistry; Metallurgy | 13 | Active |
| US7375099B2 | Malonamide derivatives | Chemistry; Metallurgy | 13 | Expired |
| US8802773B2 | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages | Chemistry; Metallurgy | 8 | Active |
| US9249179B2 | Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA | Chemistry; Metallurgy | 6 | Active |
| US10428108B2 | Difluoroketamide derivatives | Human Necessities | 5 | Active |
| US6790860B2 | Pyrrolidine derivatives | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9011919B2 | Compositions for targeted delivery of siRNA | Chemistry; Metallurgy | 3 | Active |
| US9868772B2 | Analogs of glucagon exhibiting GIP receptor activity | Human Necessities | 3 | Active |
| US7166587B2 | Carbamic acid alkyl ester derivatives | Chemistry; Metallurgy | 3 | Expired |
| US9107957B2 | Peptide-based in vivo siRNA delivery system | Chemistry; Metallurgy | 3 | Active |
| US6541638B2 | Pyrrolidine derivatives | Chemistry; Metallurgy | 2 | Expired |
| US7253158B2 | Sulfonamides | Chemistry; Metallurgy | 2 | Expired |
| US7189756B2 | Pyrrolidine derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7173109B2 | Fluorescently labeled growth hormone secretagogue | Physics | 2 | Expired |
| US9301990B2 | Small molecule conjugates for intracellular delivery of biologically active compounds | Chemistry; Metallurgy | 1 | Active |
| US10208087B2 | Peptides | Human Necessities | 1 | Active |
| US8163778B2 | Pyridines as FBPase inhibitors for treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US9198947B2 | Small molecule conjugates for intracellular delivery of nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US7186798B2 | Fluorescently labeled growth hormone secretagogue | Physics | 0 | Expired |
| US7973051B2 | Aminothiazoles as FBPase inhibitors for diabetes | Chemistry; Metallurgy | 0 | Active |
| US10947272B2 | BACE1 inhibitor peptides | Human Necessities | 0 | Active |
| US9968647B2 | Small molecule conjugates for intracellular delivery of biologically active compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.